BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32583420)

  • 1. The role of long non-coding RNAs in drug resistance of cancer.
    Zhang HD; Jiang LH; Zhong SL; Li J; Sun DW; Hou JC; Wang DD; Zhou SY; Tang JH
    Clin Genet; 2021 Jan; 99(1):84-92. PubMed ID: 32583420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
    Singh D; Khan MA; Siddique HR
    Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs regulate drug resistance in cancer.
    Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
    Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNAs Roles in Chemoresistance of Cancer Cells.
    Taghvimi S; Abbaszadeh S; Banan FB; Fard ES; Jamali Z; Najafabadi MA; Savardashtaki A; Movahedpour A
    Curr Mol Med; 2022; 22(8):691-702. PubMed ID: 34711162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells.
    Xiong XD; Ren X; Cai MY; Yang JW; Liu X; Yang JM
    Drug Resist Updat; 2016 May; 26():28-42. PubMed ID: 27180308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA as a multifunctional regulator in cancer multi-drug resistance.
    He J; Zhu S; Liang X; Zhang Q; Luo X; Liu C; Song L
    Mol Biol Rep; 2021 Aug; 48(8):1-15. PubMed ID: 34333735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
    Jin KT; Lu ZB; Lv JQ; Zhang JG
    RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs and endometrial cancer.
    Liu H; Wan J; Chu J
    Biomed Pharmacother; 2019 Nov; 119():109396. PubMed ID: 31505425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-coding RNAs and Drug Resistance.
    Pan JJ; Xie XJ; Li X; Chen W
    Asian Pac J Cancer Prev; 2015; 16(18):8067-73. PubMed ID: 26745040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
    Abu N; Hon KW; Jeyaraman S; Jamal R
    Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs in cancer drug resistance development.
    Majidinia M; Yousefi B
    DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin.
    Taheri M; Shoorei H; Tondro Anamag F; Ghafouri-Fard S; Dinger ME
    Exp Mol Pathol; 2021 Dec; 123():104602. PubMed ID: 33422487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.
    Fang C; Wang L; Gong C; Wu W; Yao C; Zhu S
    J Cell Mol Med; 2020 Mar; 24(6):3282-3291. PubMed ID: 32048814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress and the emerging role of lncRNAs in cancer drug resistance; focusing on signaling pathways.
    Saadh MJ; Rasulova I; Almoyad MAA; Kiasari BA; Ali RT; Rasheed T; Faisal A; Hussain F; Jawad MJ; Hani T; Sârbu I; Lakshmaiya N; Ciongradi CI
    Pathol Res Pract; 2024 Jan; 253():154999. PubMed ID: 38118218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
    Zhang X; Yang H
    Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.